BioSpace News Archive

3D Bioprinting Market: Rise in Prevalence of Regenerative Therapies to Drive the Global Market

Wilmington, Delaware, United States: Additive manufacturing or 3D printing is witnessing innovations left, right and center.

June 29, 2022
·
5 min read
Expansion of Neuropathic Pain Market Projected to be Supported by Significant Investment

Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system.

June 29, 2022
·
5 min read
Neonatal and Infant Care Equipment Market Size will Grow Profitably in the Near Future

Wilmington, Delaware, United States: For the lack of immunity power, which is only starting to grow since birth, neonatal or infant are more prone to several types of diseases than the adults.

June 29, 2022
·
5 min read
Burgeoning Oncology Research to Provide Tailwinds to Gene Therapy Market Growth, Surpassing US$ 10 Billion by 2032: Fact.MR Study

Fact.MR – A Market Research and Competitive Intelligence Provider: The global gene therapy market advocates that the industry is poised to incline at an 18.5% value CAGR from 2022-2032, expected to close at a valuation of US$ 10.1 Billion.

June 29, 2022
·
7 min read
Global Respiratory Care Devices Market: Promising Growth Opportunities for the Market Players | Forecast, 2031

The global respiratory care devices market has been gaining traction in the last few years.

June 29, 2022
·
8 min read
Trauma and Extremities Market to Record Ascending Growth During the Forecast Period

Wilmington, Delaware, United States: Trauma and extremities devices include various simple and complex devices, growing at a considerable pace.

June 29, 2022
·
5 min read
Drug Development

Avacta Announces Second Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-doxorubicin

Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.

June 29, 2022
·
2 min read
Drug Development

Positive Data from the Clinical Phase I MAD Study with AlzeCure’s Alzheimer’s Pproject NeuroRestore ACD856

AlzeCure Pharma AB announced that the company has completed the clinical phase I study with repeated dosing of the drug candidate ACD856, with a focus on Alzheimer’s disease.

June 29, 2022
·
6 min read
Biotech Bay

Visby Medical Expands Series E Round to Over $135 Million

Visby Medical™, a leading medical diagnostic company, announced that it expanded its over-subscribed Series E financing round to include an additional $35 million for a total of over $135 million raised in the round.

June 29, 2022
·
3 min read
Hemoglobinopathies Market to Witness Widespread Expansion During 2027

Wilmington, Delaware, United States: Hemoglobinopathies are a group of blood disorders and diseases that impact the red blood cells.

June 29, 2022
·
5 min read